Any COVID-19 vaccine is likely to be given first to higher risk groups before it is given to children. But we still need vaccines that are safe and effective for them too.
L’expertise universitaire, l’exigence journalistique
Articles sur COVID-19
Affichage de 4201 à 4220 de 7942 articles
Researchers are imagining what the world might look like in 2048 — and the new forms of inequality and injustice that might exist.
Leaders need to focus on minimizing the COVID-19 harm to both lives and livelihoods if they’re to win support from the electorate.
No kissing, jumping up and down on the dance floor, or buffets. Sounds like a COVID wedding.
Recent findings from social neuroscience show us how we can make virtual interactions almost as beneficial as real world ones.
Slums are a challenge for controlling the pandemic. Strengthening their fragile healthcare provision would help mitigate the effects of COVID-19 and future pandemics.
A space the size of 284 Bluewaters is surplus to requirements.
Here are some books that will make reading time more enjoyable for children and the adults reading to or with them.
Diversification into related businesses can provide a firmer financial footing.
Some atmospheric pollutants actually help cool the planet, but the sudden shutdown of heavy industry threatened to purge them.
Two legal scholars explain what’s causing the USPS mail delays, what they mean for the election and the agency’s deeper financial problems.
A composer and performer talks about the impact of the pandemic on classical music performances and his experience composing in isolation.
An optical sensor that can detect individual molecules promises early detection of diseases and environmental contamination.
There’s still a lot of uncertainty, but the picture is gradually getting clearer – here’s what we know so far.
Optimists often assume that bad things won’t befall them – a dangerous outlook during the coronavirus pandemic.
If only 1% of the Pacific’s population was permitted to work permanently in Australia, this would bring more benefits to the region than Australia’s annual aid contribution.
Massive borrowing to fund NZ’s economic recovery due to COVID-19 cannot be written off without the risk of worsening the crisis it was designed to meet.
Coronavirus trial protocols have only recently been released. This is what they show.
It can be hard to work out what calculations to make when deciding on private health. So we asked a health economist to break it down.
The country has built a fairly good reputation for well-functioning, democratic governance.
Les contributeurs les plus fréquents
-
Professorial Fellow, University of Canberra
-
Associate Professor, Epidemiology, Deakin University
-
Professor of Economics, UNSW Sydney
-
Chair in Epidemiology, Deakin University
-
Professor of Global Biosecurity, NHMRC L3 Research Fellow, Head, Biosecurity Program, Kirby Institute, UNSW Sydney
-
Professor of Biostatistics and Epidemiology, University of South Australia
-
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
-
Senior Research Fellow in Global Health, University of Southampton
-
Visiting Fellow, Crawford School of Public Policy, Australian National University
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Professor of Medicine, University of East Anglia
-
Associate professor, UNSW Sydney
-
Professor of Public Health, University of Sheffield
-
Professor of Medicine, University of Virginia
-
Associate Professor of Bioethics, University of Portsmouth
